Evidence map›Paper›PMID 38256437›Full record

ReviewJournal of clinical medicine2024

Chronic Obstructive Lung Disease: Treatment Guidelines and Recommendations for Referral and Multidisciplinary Continuity of Care.

Javier De Miguel-Díez, Alberto Fernández-Villar, Esperanza Doña Díaz, Marta Padilla Bernáldez, Eva Trillo-Calvo, Jesús Molina París, Miriam Barrecheguren, José Miguel Valero Pérez, María Teresa Ramírez Prieto

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Javier De Miguel-DíezServicio de Neumología, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), 28007 Madrid, Spain.ORCID 0000-0003-4543-573X
Alberto Fernández-VillarServicio de Neumología, Hospital Álvaro Cunqueiro, Grupo NeumoVigo, Instituto de Investigación Sanitaria Galicia Sur, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), 36312 Vigo, Spain.ORCID 0000-0001-7407-5249
Esperanza Doña DíazUnidad de Asistencia al Paciente EPOC, UGC Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Regional Universitario de Málaga, 29010 Málaga, Spain.
Marta Padilla BernáldezHospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Eva Trillo-CalvoInstitute for Health Research Aragón, Centro de Salud Campo de Belchite, 50130 Belchite, Spain.ORCID 0000-0003-0816-3579
Jesús Molina ParísCentro de Salud Francia, Dirección Asistencial Oeste, 28943 Fuenlabrada, Spain.ORCID 0000-0002-4716-3152
Miriam BarrechegurenServicio de Neumología, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
José Miguel Valero PérezCentro de Salud Bétera, 46117 Bétera, Spain.
María Teresa Ramírez PrietoServicio de Neumología, Hospital Universitario Infanta Sofía, 28702 Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESHospital Regional Universitario de Málaga · ESHospital Universitario 12 De Octubre · ESHospital Universitario Infanta Sofía · ESUniversidad Complutense de Madrid · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic Obstructive Pulmonary Disease (COPD) constitutes a major public health problem, and it is anticipated that its prevalence will continue to increase in the future. Its progressive nature requires a continuous and well-coordinated care approach. The follow-up for COPD should primarily focus on disease screening and control, which includes monitoring of pulmonary function, prevention of exacerbations, identification of aggravating factors and comorbidities, as well as ensuring treatment adequacy and adherence. However, existing clinical practice guidelines and consensus documents offer limited recommendations for the follow-up. In this context, we undertake a review of COPD treatment and the continuity of care recommendations endorsed by several scientific societies. Moreover, we underscore the importance of the involvement of nursing and community pharmacy in this process, as well as the utilization of quality indicators in the provision of care for the disease.

Indexed as

chronic obstructive pulmonary diseasecontinuity of patient carereferral and consultation

Identifiers

PMID38256437
PMCPMC10815941
OpenAlexW4390614388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.